Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,749-8,760 of 10,592
Drug study icon
CompletedNCT01058668

Safety and Efficacy of Cariprazine for Bipolarity type I

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Croatia, Romania, ...
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
CompletedNCT01058096

Safety and Efficacy of Cariprazine for Mania

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, India
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
CompletedNCT01104779

Safety and Efficacy of Cariprazine in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Colombia, India, ...
Sponsor
Forest Laboratories
Condition
Schizophrenia
Drug study icon
CompletedNCT05071430

Safety and Efficacy of HB-1 for Panic Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AnxietyDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
HB BioTech, LLC
Condition
Anxiety
Drug study icon
CompletedNCT00852202

Safety and Efficacy of RGH-188 (Cariprazine) in Depression in bipolarity

This study exists to understand whether the medication RGH-188 is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Forest Laboratories
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.